secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2026-04-10T23:59:59+00:00
Accession:  0001193125-26-151209
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology CMO Mark Eisner to step down effective April 24, 2026
-----------------------------------------------------------------------

- Mark Eisner, EVP and Chief Medical Officer, leaving role on April 24, 2026.
- Company has initiated search for a successor; no replacement named yet.
- Departure disclosed in Item 5.02 of the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312526151209/0001193125-26-151209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312526151209/d121549d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-151209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer